TT-014

N/A

Report date: 2024/02/06 16:32:24
NME

Base Information

Drug NameTT-014
Drug Alias NameTT-014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor modulators
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsRectal NeoplasmsColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTeon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRectal NeoplasmsColorectal NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A